Torrent Pharma Assigned Strong ESG Ratings by Crisil ESG Ratings
Torrent Pharmaceuticals Limited has been assigned strong ESG ratings by Crisil ESG Ratings & Analytics Limited. The company received a 'Crisil ESG 66' rating and a 'Crisil Core ESG 74' rating.
While positive, ESG ratings themselves do not typically have an immediate or significant direct financial impact on the company's operations or stock price in the short term. It is more of a long-term indicator of company quality and risk.
The assignment of strong ESG ratings by a reputable agency like Crisil is generally viewed positively by investors and stakeholders, indicating good corporate governance and sustainability practices.
Torrent Pharmaceuticals Limited has received strong ESG (Environmental, Social, and Governance) ratings from Crisil ESG Ratings & Analytics Limited. The company announced that Crisil ESG Ratings, a SEBI registered ESG Rating Provider, has independently assigned the rating of ‘Crisil ESG 66’ and the Core ESG rating of ‘Crisil Core ESG 74’.
This intimation is provided pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the relevant SEBI Master Circular. The announcement was made on 17th July 2026.
What to do with a filing like this
Torrent Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under esg reports. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Torrent Pharmaceuticals Limited. Read the original for the full detail.